Erythromycin with zinc acetate
Brand names: Zineryt
This is a topical combination solution of the macrolide antibacterial erythromycin with zinc acetate, applied to the skin for inflammatory acne vulgaris.
Adult dose
Dose independently re-sourced from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — clinician-reviewed. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substances, to other macrolide antibiotics, or to any of the excipients
Side effects
- Pruritus (rare)
- Erythema (rare)
- Skin irritation and skin burning sensation
- Dry skin
- Skin exfoliation
- Hypersensitivity; acute generalised exanthematous pustulosis (AGEP) reported after systemic administration
Interactions
- No interaction studies have been performed (SPC section 4.5)
Clinical monograph
How it works
Erythromycin inhibits bacterial protein synthesis to suppress Cutibacterium acnes and reduce inflammation, while zinc acetate improves cutaneous penetration and may itself contribute anti-inflammatory and astringent effects.
Prescribing in practice
- As with all topical antibiotics for acne, it should be combined with benzoyl peroxide and used in time-limited courses to minimise antibiotic resistance rather than as prolonged monotherapy.
- Avoid combining with other antibiotics of a different class to reduce selection of resistant organisms.
- Apply across the whole affected area and avoid contact with the eyes, lips and mucous membranes.
Monitoring
No laboratory monitoring is required; review acne response, local tolerability and the continued need for treatment to limit resistance.
Counselling the patient
- Reconstitute and apply the solution as directed to the entire affected area of clean, dry skin.
- Mild dryness, redness or a burning sensation can occur and usually settles.
- Keep using benzoyl peroxide as advised and complete the agreed course to reduce the chance of resistance.
Evidence & guidelines
Topical erythromycin with zinc has been used for acne with supporting clinical studies, and NICE recommends pairing topical antibiotics with benzoyl peroxide to limit resistance.
Reference: NICE NG198; BAD acne guidance; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acne Severity Classification (IGA Scale) · Acne
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Acute Otitis Media — Antibiotic or Observation (AAP 2013) · Otitis Media
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Diagnosis and Hospitalisation (CDC Criteria) · Gynaecological Infections
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD